YAKUGAKU ZASSHI 1979-12-01

[The biological fate of 4-butyl-4-(beta-carboxypropionyloxymethyl)-1,2-diphenyl-3,5-pyrazolidinedione(suxibuzone), antiinflammatory drug. I. Plasma levels and urinary excretion after oral administration of suxibuzone (author's transl)].

T Shindo, Y Yasuda, K Taira, N Mitani, A Kanda, A Akazawa

Index: Yakugaku Zasshi 99(12) , 1186-200, (1979)

Full Text: HTML

Structure	Name/CAS No.	Molecular Formula	Articles
	Suxibuzone CAS:27470-51-5	C₂₄H₂₆N₂O₆

[The biological fate of 4-butyl-4-(beta-carboxypropionyloxym...
1980-03-01
[Yakugaku Zasshi 100(3) , 272-9, (1980)]

Pro-drugs of non-steroidal anti-inflammatory agents.
1983-01-01
[Eur. J. Rheumatol. Inflamm. 6(2) , 141-2, (1983)]

Antemortem diagnosis of a distal axonopathy causing severe s...
2010-01-01
[J. Vet. Intern. Med. 24(1) , 220-3, (2010)]

Disposition of human drug preparations in the horse. I. Rect...
1991-06-01
[J. Vet. Pharmacol. Ther. 14(2) , 145-9, (1991)]

Effects of top-dress formulations of suxibuzone and phenylbu...
2009-01-01
[Vet. Ther. 10(3) , 113-20, (2009)]